PortfoliosLab logoPortfoliosLab logo
Tilray, Inc. (TLRY)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US88688T1007
CUSIP
88688T100
IPO Date
Jul 19, 2018

Highlights

Market Cap
$713.92M
Enterprise Value
$713.92M
EPS (TTM)
-$27.99
Total Revenue (TTM)
$1.08B
Gross Profit (TTM)
$304.37M
EBITDA (TTM)
-$2.92B
Year Range
$3.51 - $23.20
Target Price
$7.33

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Tilray, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Tilray, Inc. (TLRY) has returned -28.35% so far this year and -1.60% over the past 12 months.


Tilray, Inc.

1D
8.01%
1M
-17.79%
YTD
-28.35%
6M
-62.60%
1Y
-1.60%
3Y*
-36.53%
5Y*
-50.75%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 19, 2018, TLRY's average daily return is +0.06%, while the average monthly return is +1.17%. At this rate, your investment would double in approximately 5.0 years.

Historically, 35% of months were positive and 65% were negative. The best month was Aug 2018 with a return of +195.0%, while the worst month was Mar 2020 at -52.3%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 9 months.

On a daily basis, TLRY closed higher 43% of trading days. The best single day was Sep 29, 2025 with a return of +60.9%, while the worst single day was Feb 11, 2021 at -49.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-17.39%5.50%-17.79%-28.35%
2025-21.05%-30.00%-10.54%-26.22%-12.24%-2.65%40.18%137.56%25.36%-22.54%-39.33%11.07%-32.11%
2024-20.43%-5.46%42.77%-0.00%-27.13%-7.78%22.29%-15.76%2.92%-6.82%-18.29%-0.75%-42.17%
202320.45%-12.65%-10.60%-7.11%-28.94%-6.59%62.18%17.00%-19.26%-24.69%0.56%27.07%-14.50%
2022-15.22%2.35%27.38%-35.91%-9.84%-30.51%16.99%4.11%-27.63%48.00%-4.91%-30.49%-61.74%
2021119.13%34.59%-6.69%-19.31%-9.11%8.46%-19.19%-6.30%-17.53%-8.77%-1.75%-30.53%-14.89%

Benchmark Metrics

Tilray, Inc. has an annualized alpha of -5.24%, beta of 1.52, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since July 20, 2018.

  • This stock participated in 205.38% of S&P 500 Index downside but only 59.75% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-5.24%
Beta
1.52
0.07
Upside Capture
59.75%
Downside Capture
205.38%

Return for Risk

Risk / Return Rank

TLRY ranks 46 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


TLRY Risk / Return Rank: 4646
Overall Rank
TLRY Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
TLRY Sortino Ratio Rank: 5959
Sortino Ratio Rank
TLRY Omega Ratio Rank: 5454
Omega Ratio Rank
TLRY Calmar Ratio Rank: 4040
Calmar Ratio Rank
TLRY Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Tilray, Inc. (TLRY) and compare them to a chosen benchmark (S&P 500 Index).


TLRYBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.01

0.90

-0.91

Sortino ratio

Return per unit of downside risk

1.17

1.39

-0.22

Omega ratio

Gain probability vs. loss probability

1.13

1.21

-0.08

Calmar ratio

Return relative to maximum drawdown

-0.03

1.40

-1.43

Martin ratio

Return relative to average drawdown

-0.06

6.61

-6.66

Explore TLRY risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Tilray, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Tilray, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Tilray, Inc. was 99.83%, occurring on Jun 20, 2025. The portfolio has not yet recovered.

The current Tilray, Inc. drawdown is 99.70%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.83%Sep 20, 20181696Jun 20, 2025
-25.76%Jul 23, 20187Jul 31, 201813Aug 17, 201820
-13.32%Sep 6, 20182Sep 7, 20182Sep 11, 20184
-8.94%Sep 14, 20181Sep 14, 20181Sep 17, 20182
-4.93%Aug 30, 20181Aug 30, 20181Aug 31, 20182

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Tilray, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Tilray, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for TLRY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TLRY has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items